Kura Oncology (KURA) Cash from Operations (2010 - 2026)
Kura Oncology (KURA) reported Cash from Operations of 85854000.0 for Q1 2026, down 19.36% year-over-year from 106469321.69 in Q1 2025, and down 173.21% on a QoQ basis from 117273000.0 in Q4 2025.
Kura Oncology (KURA) has 17 years of Cash from Operations data on file, last reported at 85854000.0 in Q1 2026.
- Quarterly Cash from Operations fell 19.36% year-over-year to 85854000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 77985000.0 (down 170.11% YoY) and the FY2025 annual result came in at 64058000.0, down 147.69% from the prior year.
- Cash from Operations fell to 85854000.0 in Q1 2026 per KURA's latest filing, from 117273000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 269131000.0 in Q4 2024 and bottomed at 85854000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 32181000.0 (2022), against an average of 14734176.47.
- The widest annual swing landed in 2024, when Cash from Operations surged 884.46%; it then sank 85.61% in 2025.
- Tracing KURA's Cash from Operations over 5 years: stood at 26530000.0 in 2022, then fell by 29.32% to 34308000.0 in 2023, then surged by 884.46% to 269131000.0 in 2024, then slumped by 56.43% to 117273000.0 in 2025, then slumped by 173.21% to 85854000.0 in 2026.
- Per Business Quant, the three latest KURA Cash from Operations figures stand at 85854000.0 (Q1 2026), 117273000.0 (Q4 2025), and 80627000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -85.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.85 Mn |
| Mar 31, 2026 | -85.85 Mn |
| Dec 31, 2025 | 117.27 Mn |
| Dec 31, 2025 | 117.27 Mn |
| Sep 30, 2025 | -80.63 Mn |
| Sep 30, 2025 | -80.63 Mn |
| Jun 30, 2025 | -28.78 Mn |
| Jun 30, 2025 | -28.78 Mn |
| Mar 31, 2025 | -71.93 Mn |
| Mar 31, 2025 | -71.93 Mn |
| Dec 31, 2024 | 269.13 Mn |
| Dec 31, 2024 | 269.13 Mn |
| Sep 30, 2024 | -43.44 Mn |
| Sep 30, 2024 | -43.44 Mn |
| Jun 30, 2024 | -42.53 Mn |
| Jun 30, 2024 | -42.53 Mn |
| Mar 31, 2024 | -48.84 Mn |
| Mar 31, 2024 | -48.84 Mn |
| Dec 31, 2023 | -34.31 Mn |
| Dec 31, 2023 | -34.31 Mn |
| Sep 30, 2023 | -29.03 Mn |
| Sep 30, 2023 | -29.03 Mn |
| Jun 30, 2023 | -25.62 Mn |
| Jun 30, 2023 | -25.62 Mn |
| Mar 31, 2023 | -35.87 Mn |
| Mar 31, 2023 | -35.87 Mn |
| Dec 31, 2022 | -26.53 Mn |
| Dec 31, 2022 | -26.53 Mn |
| Sep 30, 2022 | -21.01 Mn |
| Sep 30, 2022 | -21.01 Mn |
| Jun 30, 2022 | -30.34 Mn |
| Jun 30, 2022 | -30.34 Mn |
| Mar 31, 2022 | -32.18 Mn |
| Mar 31, 2022 | -32.18 Mn |
| Dec 31, 2021 | -23.37 Mn |
| Dec 31, 2021 | -23.37 Mn |
| Sep 30, 2021 | -24.59 Mn |
| Sep 30, 2021 | -24.59 Mn |
| Jun 30, 2021 | -28.07 Mn |
| Jun 30, 2021 | -28.07 Mn |
| Mar 31, 2021 | -28.52 Mn |
| Mar 31, 2021 | -28.52 Mn |
| Dec 31, 2020 | -18.31 Mn |
| Dec 31, 2020 | -18.31 Mn |
| Sep 30, 2020 | -16.97 Mn |
| Sep 30, 2020 | -16.97 Mn |
| Jun 30, 2020 | -14.73 Mn |
| Jun 30, 2020 | -14.73 Mn |
| Mar 31, 2020 | -19.82 Mn |
| Mar 31, 2020 | -19.82 Mn |
| Dec 31, 2019 | -13.93 Mn |
| Dec 31, 2019 | -13.93 Mn |
| Sep 30, 2019 | -12.15 Mn |
| Sep 30, 2019 | -12.15 Mn |
| Jun 30, 2019 | -14.43 Mn |
| Jun 30, 2019 | -14.43 Mn |
| Mar 31, 2019 | -14.25 Mn |
| Mar 31, 2019 | -14.25 Mn |
| Dec 31, 2018 | -10.21 Mn |
| Dec 31, 2018 | -10.21 Mn |
| Sep 30, 2018 | -13.00 Mn |
| Sep 30, 2018 | -13.00 Mn |
| Jun 30, 2018 | -12.59 Mn |
| Jun 30, 2018 | -12.59 Mn |
| Mar 31, 2018 | -12.85 Mn |
| Mar 31, 2018 | -12.85 Mn |
| Dec 31, 2017 | -7.47 Mn |
| Dec 31, 2017 | -7.47 Mn |
| Sep 30, 2017 | -6.24 Mn |
| Sep 30, 2017 | -6.24 Mn |
| Jun 30, 2017 | -6.11 Mn |
| Jun 30, 2017 | -6.11 Mn |
| Mar 31, 2017 | -8.62 Mn |
| Mar 31, 2017 | -8.62 Mn |
| Dec 31, 2016 | -6.74 Mn |
| Dec 31, 2016 | -6.74 Mn |
| Sep 30, 2016 | -5.47 Mn |
| Sep 30, 2016 | -5.47 Mn |
| Jun 30, 2016 | -5.83 Mn |
| Jun 30, 2016 | -5.83 Mn |
| Mar 31, 2016 | -7.31 Mn |
| Mar 31, 2016 | -7.31 Mn |
| Dec 31, 2015 | -5.61 Mn |
| Dec 31, 2015 | -5.61 Mn |
| Sep 30, 2015 | -4.43 Mn |
| Sep 30, 2015 | -4.43 Mn |
| Jun 30, 2015 | -3.77 Mn |
| Jun 30, 2015 | -3.77 Mn |
| Mar 31, 2015 | -4.12 Mn |
| Mar 31, 2015 | -4.12 Mn |
| Dec 31, 2014 | -849,000.00 |
| Dec 31, 2014 | -849,000.00 |
| Sep 30, 2014 | -16,000.00 |
| Sep 30, 2014 | -16,000.00 |
| Jun 30, 2014 | -1,250.00 |
| Jun 30, 2014 | -1,250.00 |
| Mar 31, 2014 | -400.00 |
| Mar 31, 2014 | -400.00 |
| Dec 31, 2013 | -4,012.00 |
| Dec 31, 2013 | -4,012.00 |
| Sep 30, 2013 | -8,125.00 |
| Sep 30, 2013 | -8,125.00 |
| Jun 30, 2013 | -9,196.00 |
| Jun 30, 2013 | -9,196.00 |
| Mar 31, 2013 | -1,901.00 |
| Mar 31, 2013 | -1,901.00 |
| Dec 31, 2012 | -784.00 |
| Dec 31, 2012 | -784.00 |
| Sep 30, 2012 | -3,895.00 |
| Sep 30, 2012 | -3,895.00 |
| Jun 30, 2012 | -14,262.00 |
| Jun 30, 2012 | -14,262.00 |
| Mar 31, 2012 | -5,477.00 |
| Mar 31, 2012 | -5,477.00 |
| Dec 31, 2011 | -1,935.00 |
| Dec 31, 2011 | -1,935.00 |
| Sep 30, 2011 | -3,100.00 |
| Sep 30, 2011 | -3,100.00 |
| Jun 30, 2011 | -15,379.00 |
| Jun 30, 2011 | -15,379.00 |
| Mar 31, 2011 | -2,264.00 |
| Mar 31, 2011 | -2,264.00 |
| Dec 31, 2010 | -356.00 |
| Dec 31, 2010 | -356.00 |
| Sep 30, 2010 | -3,506.00 |
| Sep 30, 2010 | -3,506.00 |